Liminatus Pharma Inc. Share

Liminatus Pharma Inc. (LIMN) is a United States-based biopharmaceutical company traded on the NASDAQ exchange. The company focuses on the research, development, and commercialization of novel therapeutics, primarily in the areas of oncology and immunology. Liminatus Pharma is dedicated to addressing unmet medical needs through innovative drug discovery and clinical development programs. They strive to improve patient outcomes by creating targeted therapies designed to selectively modulate the immune system and combat various cancers. With a commitment to scientific excellence and a pipeline of promising drug candidates, Liminatus Pharma aims to become a leading force in the biopharmaceutical industry, delivering meaningful advancements in healthcare and generating long-term value for its stakeholders through strategic partnerships and focused execution.